Taiwan FDA registration 6542038dab6dd4934e27c09a7f23d720

Ebil Epstein-Barr virus early antigen IgM antibody test group

TW: 艾必爾EB病毒早期抗原IgM抗體測試組

Taiwan·Risk Class 1·IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH·Registered Nov 04, 2005 – Nov 04, 2010Cancelled

Registration details

Analysis ID: 6542038dab6dd4934e27c09a7f23d720
Customs Code: DHA04400174203

Company information

Manufacturer: IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH
Manufacturer Country: Germany
Authorized Representative: Dachen Biotechnology Co., Ltd

Product details

Intended Use: Enzyme immunoassay was used to quantitatively and quantitatively detect IgM antibodies to the early antigen of Epstein-Barr virus in human serum and plasma.
Product Type (Level 1): C Immunology and microbiology
Import Information: import

Dates and status

Registration Date: Nov 04, 2005
Expiry Date: Nov 04, 2010
Cancellation Date: Nov 06, 2012

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Ebil Epstein-Barr virus early antigen IgM antibody test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 6542038dab6dd4934e27c09a7f23d720 and manufactured by IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH. The authorized representative in Taiwan is Dachen Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.